MGNX - Macrogenics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - MGNX (1125345)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
21 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-03-06
MGNXPeters Jeffrey StuartSVP, GCS - Sale+OE$21.50-19,6258,895-69%-$421,938
D
2024-03-04
MGNXRisser Eric BlasiusCOOS - Sale+OE$19.76-41,15938,900-51%-$813,501
D
2024-03-04
MGNXSpitznagel ThomasSVP, Technical OpsS - Sale+OE$20.00-10,0008,316-55%-$200,000
2024-03-04
MGNXKarrels JamesSVP, CFO, SecretaryS - Sale$20.50-30,000171,452-15%-$615,000
2024-02-26
MGNXPeters Jeffrey StuartSVP, GCS - Sale$17.22-16,1248,895-64%-$277,655
2024-02-07
MGNXBonvini EzioSVP, Research, CSOS - Sale$18.00-3,33471,334-4%-$60,012
D
2024-02-05
MGNXPeters Jeffrey StuartSVP, GCS - Sale+OE$16.50-76,2510-100%-$1,258,142
2024-02-01
MGNXBonvini EzioSVP, Research, CSOS - Sale$15.00-13,31674,668-15%-$199,740
2024-01-19
MGNXBonvini EzioSVP, Research, CSOS - Sale$12.00-13,31687,984-13%-$159,792
2023-12-20
MGNXBonvini EzioSVP, Research, CSOS - Sale$10.08-18,880101,300-16%-$190,310
2023-10-02
MGNXBiotech Target N V10%P - Purchase$4.46+150,0009,929,963+2%+$669,585
2023-09-07
MGNXBiotech Target N V10%P - Purchase$5.26+200,0009,779,963+2%+$1,052,840
2023-08-30
MGNXHurwitz EdwardDirP - Purchase$4.91+15,00033,074+83%+$73,650
2023-03-10
MGNXPeters Jeffrey StuartSVP, GCS - Sale$6.03-5,3720-100%-$32,393
2023-02-14
MGNXBiotech Target N V10%P - Purchase$5.07+500,0009,579,963+6%+$2,532,600
2023-01-19
MGNXBiotech Target N V10%P - Purchase$5.30+150,0009,079,963+2%+$794,925
M
2022-12-23
MGNXBiotech Target N V10%P - Purchase$5.75+400,0008,929,963+5%+$2,298,600
2022-11-22
MGNXBiotech Target N V10%P - Purchase$5.96+300,0008,529,963+4%+$1,788,180
M
2022-10-21
MGNXBiotech Target N V10%P - Purchase$4.50+500,0008,229,963+6%+$2,247,600
M
2022-10-19
MGNXBiotech Target N V10%P - Purchase$3.89+454,3997,729,963+6%+$1,767,484
2022-06-15
MGNXKarrels JamesSVP, CFO, SecretaryP - Purchase$2.47+40,000191,776+26%+$98,800

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top